HB-501

N/A

Report date: 2025/11/19 20:01:17

Base Information

Drug NameHB-501
Drug Alias NameHB-501
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHookipa Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHookipa Biotech Gmbh
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A